These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1671274)

  • 41. The Safety and Effectiveness of Flecainide in Children in the Current Era.
    Cunningham T; Uzun O; Morris R; Franciosi S; Wong A; Jeremiasen I; Sherwin E; Sanatani S
    Pediatr Cardiol; 2017 Dec; 38(8):1633-1638. PubMed ID: 28840327
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bronchoalveolar lavage cellular analysis and gallium lung scan in the assessment of patients with amiodarone-induced pneumonitis.
    Xaubet A; Roca J; Rodriguez-Roisin R; Herranz J; Marin A; Lomeña F; Montserrat JM; Agustí-Vidal A
    Respiration; 1987; 52(4):272-80. PubMed ID: 3438590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flecainide in cancer nerve pain.
    Lancet; 1991 Jun; 337(8753):1347. PubMed ID: 1674319
    [No Abstract]   [Full Text] [Related]  

  • 44. [QT prolongation and induction of torsades de pointe by flecainide. Apropos of a case].
    Wickers F; Haissaguere M; Palussiere J
    Arch Mal Coeur Vaiss; 1988 Oct; 81(10):1283-5. PubMed ID: 3146965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conversion of supraventricular arrhythmias to sinus rhythm using flecainide.
    Goy JJ; Grbic M; Hurni M; Finci L; Maendly R; Duc J; Sigwart U
    Eur Heart J; 1985 Jun; 6(6):518-24. PubMed ID: 4043101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flecainide-associated bradycardia-dependent torsade de pointes: another potential mechanism of proarrhythmia.
    Kim HS; Pak HN; Park JS; Kim SS
    Pacing Clin Electrophysiol; 2013 Mar; 36(3):e84-6. PubMed ID: 21029131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral flecainide for suppression of ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
    Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Anomalies of the T waves induced by flecainide].
    Stoltz JP; Weingrod M; Leroy G; Halphen C; Haïat R
    Arch Mal Coeur Vaiss; 1988 Aug; 81(8):1009-12. PubMed ID: 3144249
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Anti-arrhythmia effect of flecainide in acute myocardial infarct in comparison with lidocaine].
    Thale J; Gülker H; Bender F; Heuer H; Kristek J; Schindelhauer F; Hübner G
    Med Welt; 1981 Jul; 32(29):1151-3. PubMed ID: 7266352
    [No Abstract]   [Full Text] [Related]  

  • 50. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Interstitial pneumopathy and amiodarone].
    Tatti V; Ramelli G
    Schweiz Med Wochenschr; 1986 Mar; 116(12):377-82. PubMed ID: 2421401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; ten Cate FJ; Jovanovic A; Hagemeijer F; Withagen A; Polak BC; Roelandt J; Hugenholtz PG
    Eur Heart J; 1984 Oct; 5(10):814-23. PubMed ID: 6499854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The development and testing of intravenous dosing regimens: application to flecainide for the suppression of ventricular arrhythmias.
    Wang T; Siddoway LA; Thompson KA; Conard GJ; Bergstrand RH; Kvam D; Roden DM; Woosley RL
    Clin Pharmacol Ther; 1988 May; 43(5):499-508. PubMed ID: 3130211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-resolution computed tomography findings of acute respiratory distress syndrome, acute interstitial pneumonia, and acute exacerbation of idiopathic pulmonary fibrosis.
    Ichikado K
    Semin Ultrasound CT MR; 2014 Feb; 35(1):39-46. PubMed ID: 24480142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pulmonary injury induced by phorbol myristate acetate following intravenous administration in rabbits. Acute respiratory distress followed by pulmonary interstitial pneumonitis and pulmonary fibrosis.
    McCall CE; Taylor RG; Cousart SL; Woodruff RD; Lewis JC; O'Flaherty JT
    Am J Pathol; 1983 May; 111(2):258-62. PubMed ID: 6846505
    [No Abstract]   [Full Text] [Related]  

  • 57. Characterization of an anesthetized dog model of transient cardiac ischemia and rapid pacing: a pilot study for preclinical assessment of the potential for proarrhythmic risk of novel drug candidates.
    Damiano BP; van der Linde HJ; Van Deuren B; Somers Y; Lubomirski M; Teisman A; Gallacher DJ
    J Pharmacol Toxicol Methods; 2015; 72():72-84. PubMed ID: 25450838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Azoulay E; Herigault S; Levame M; Brochard L; Schlemmer B; Harf A; Delclaux C
    Crit Care Med; 2003 May; 31(5):1442-8. PubMed ID: 12771616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flecainide: evidence of non-linear kinetics.
    Boriani G; Strocchi E; Capucci A; Callivà R; Frabetti L; Ambrosioni E; Magnani B
    Eur J Clin Pharmacol; 1991; 41(1):57-9. PubMed ID: 1782978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Worsening of ventricular arrhythmia in the dynamic ECG in patients treated with anti-arrhythmia drugs].
    Lanza GA; Tamburi S; Mondello Malvestiti FM; Rebuzzi AG; Lucente M
    Cardiologia; 1988 Jun; 33(6):613-8. PubMed ID: 3139292
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.